x

Health

WHO Grants Emergency Approval to 2nd Chinese COVID Vaccine

GENEVA — The World Health Organization has issued an emergency use listing for the COVID-19 vaccine made by Sinovac for adults 18 and over, the second such authorization it has granted to a Chinese company. 

In a statement Tuesday, the U.N. health agency said data submitted to its experts showed that two doses of the vaccine prevented people from getting symptoms of COVID-19 in about half of those who got the vaccine. WHO said there were few older adults enrolled in the research, so it could not estimate how effective the vaccine was in people over 60. 

"Nevertheless, WHO is not recommending an upper age limit for the vaccine," the agency said, adding that data collected from Sinovac's use in other countries "suggest the vaccine is likely to have a protective effect in older persons."

In April, a study published by a team of scientists in Brazil confirmed a previously reported efficacy rate of over 50% for Sinovac. A real-world study in Chile in April found an efficacy rate of 67%.

Last month, WHO gave the green light to the COVID-19 vaccine made by Sinopharm. It has also licensed vaccines developed by Pfizer-BioNTech, AstraZeneca, Moderna and Johnson & Johnson.

WHO's authorization means the vaccine can be bought by donors and other U.N. agencies for use in poorer countries, including in the U.N.-backed initiative to distribute COVID-19 vaccines globally known as COVAX. The effort has been slowed considerably after its biggest supplier in India said it would not be able to provide any more vaccines until the end of the year due to the latest surge of new infections now ravaging India.

To date, there is no confirmed deal for Sinovac doses with COVAX. 

In May, Europe's drug regulator began an expedited review process for the Sinovac vaccine, but it's unclear when a decision might be made about its possible authorization for the 27-nation bloc.

Hundreds of millions of Chinese vaccines  have already been delivered to dozens of countries around the world through bilateral deals, as many nations scrambled to secure supplies after rich countries reserved the vast majority of supplies from Western pharmaceutical makers.

While China has five vaccine shots in use, the majority of its exports abroad come from two companies: Sinopharm and Sinovac. The Chinese vaccines are "inactivated" vaccines, made with killed coronavirus. 

Most other COVID-19 vaccines being used around the world, particularly in the West, are made with newer technologies that instead target the "spike" protein that coats the surface of the coronavirus.

RELATED

NEW YORK - As exceedingly challenging social and economic conditions continue to affect people living in Myanmar, a team from Mahachulalongkornrajavidyalaya University’s Chiang Mai campus in Thailand is working to help deliver basic essentials including medicine.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

A. Diamataris on “ERT” Regarding Mitsotakis’ Visit to the U.S. (Video)

ATHENS – Antonis H. Diamataris, Advisor to the Publishers of Ethnikos Kirix and The National Herald, appeared on Greek state television, in particular, on ERT1’s show ‘From Six’.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.